SizeTectonic Therapeutic (TECX) is a United States Health Care company (Miscellaneous Commercial Services) with a market value of $403M, the 2852nd largest of 3,117 United States companies the cockpit tracks. Shares closed at $20.64 on 6 Nov 2026.
Performance Over six months the shares fell 28.8%, against +9.6% for the median peer and -1.1% for the United States market (cap-weighted) — 3rd lowest of 8 in its peer set.
Valuation It trades at 1.77× book value against a peer median of 1.96× (4th cheapest of 8).
Price implies The share price implies a return on equity of about 17.9%; Tectonic Therapeutic delivers -33.8%, so the price asks more than the business earns today.
Short interest Short interest is 11.4% of the free float (15 Oct 2026).
Next results Next results expected around 25 Mar 2027 (exchange calendar; dates can move).
Relative performance
Six months, rebased to 100: Tectonic Therapeutic against the median of its 7 peers (local-currency closes).
Tectonic Therapeutic financials
Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Performance: 6-month against 1-month return
Up and to the right = strong over both horizons. Tectonic Therapeutic is the large dot.
Fundamentals: return on equity against price-to-book
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Tectonic Therapeutic is the large dot.
Capital: ROE delivered against the ROE the price implies
Above the diagonal = the price asks for a higher return on equity than the business earns today. Tectonic Therapeutic is the large dot.
Tectonic Therapeutic competitors and peer comparison
How Tectonic Therapeutic compares with its peers
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
Tectonic Therapeutic against its 7 peers (data as of 6 Nov 2026)
Measure
TECX
Peer median
Rank in peer set
1-month return
-9.3%
-2.6%
3rd lowest of 8
6-month return
-28.8%
+9.6%
3rd lowest of 8
Return on equity
-33.8%
-26.1%
4th lowest of 8
Price / book
1.77×
1.96×
4th cheapest of 8
ROE the price implies
17.9%
12.5%
3rd most demanding of 8
ROE delivered
-33.8%
-26.1%
4th lowest of 8
Peer table
Peer set: Industry: the same industry and sector in any market, nearest in size
Which companies are Tectonic Therapeutic's closest peers?
The cockpit's peer set: Oculis (OCS), Evolent Health (EVH), SBC Medical (SBC), Adlai Nortye Ltd. Sponsored ADR (ANL), Evotec (EVT.DE), OmniAb (OABI), Silence Therapeutics PLC Sponsored ADR (SLN).
Is Tectonic Therapeutic expensive compared with its peers?
On price / book it trades at 1.77× against a peer median of 1.96×, 4th cheapest of 8 in its peer set. The share price implies a return on equity of about 17.9%; Tectonic Therapeutic delivers -33.8%, so the price asks more than the business earns today.
How has Tectonic Therapeutic stock performed?
Over six months to 6 Nov 2026 the shares returned -28.8% against +9.6% for the median peer; over one year +25.6%.